The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2025

Filed:

May. 10, 2022
Applicants:

Fundació Institut D'investigació En Ciencies DE LA Salut Germans Trias I Pujol, Badalona, ES;

Gentec, S.a., Barcelona, ES;

Inventors:

Antoni Matilla Dueñas, Badalona, ES;

Ivelisse Sánchez Díaz, Badalona, ES;

Eudald Balagué Cabasés, Badalona, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/864 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); A61P 25/14 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 48/005 (2013.01); A61K 48/0058 (2013.01); A61K 48/0066 (2013.01); A61P 25/00 (2018.01); A61P 25/14 (2018.01); C12N 2750/14143 (2013.01); C12N 2830/48 (2013.01);
Abstract

The present invention provides gene therapies for the treatment of Friedreich's ataxia. Specifically, the present invention provides a nucleic acid, cloning vector and transfer vector for the production of an adeno-associated virus (AAV) vector. The nucleic acid comprises (i) a nucleic acid sequence encoding frataxin, (ii) a phospho-glycerate-kinase (PGK) promoter, and (iii) a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE). The present invention also provides a pharmaceutical composition which comprises the AAV vector or nucleic acid. Also, the AAV vector, nucleic acid or pharmaceutical composition can be used as a medicament, specifically as a medicament for the treatment of Friedreich's ataxia.


Find Patent Forward Citations

Loading…